Brookfield Finance Inc. 4.50% Perpetual Subordinated Notes (BNJ)

Total Costs & Expenses

$14.61B

Quarterly · Period ending: · USD

BNJ logo

BNJ Total Costs & Expenses

Latest reported$14.61B
BNJ Quarterly Total Costs & Expenses ($0.00 → $14.61B)
High-resolution chart · PNG

BNJ total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brookfield Finance Inc. 4.50% Perpetual Subordinated Notes Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
14,607,400,723
14,004,291,578
12,299,000,000
14,650,000,000
13,935,000,000
13,468,000,000
14,414,000,000
15,364,000,000
19,171,000,000
19,063,000,000
20,611,000,000
21,104,000,000
19,929,000,000
19,834,000,000
20,240,000,000
19,798,000,000
19,867,000,000
18,728,000,000
18,400,000,000
16,395,000,000
15,595,000,000
13,726,000,000
14,422,000,000
13,867,000,000
10,847,000,000
14,142,000,000
15,183,000,000
15,232,000,000
14,642,000,000
12,645,000,000
13,635,000,000
12,825,000,000
11,477,000,000
10,788,000,000
11,251,000,000
10,701,000,000
7,965,000,000
4,911,000,000
5,656,000,000
5,151,000,000
4,871,000,000
4,152,000,000
4,545,000,000
4,201,000,000
4,052,000,000
3,436,000,000
3,832,000,000
3,847,000,000
3,633,000,000
3,399,000,000
4,068,000,000
3,623,000,000
4,015,000,000
3,829,000,000
5,588,000,000
3,788,000,000
3,606,000,000
3,203,000,000
2,978,000,000
3,313,000,000
2,500,000,000
2,508,000,000
4,590,000,000
2,947,000,000
2,877,000,000
2,594,000,000
3,471,000,000
2,339,000,000
2,203,000,000
1,606,000,000
2,336,000,000
2,508,000,000
2,678,000,000
478,721,130
2,553,617,895
1,917,813,023
372,000,000
332,866,214
-1,922,000,000
936,916,285
211,236,521
175,282,008
1,871,811,625
1,120,000,000
924,000,000
737,000,000
1,176,490,137
344,653,106
463,369,110
475,154,839
925,429,402
503,422,741
414,172,400
360,317,855
709,153,055
368,058,337
446,670,201
388,627,213
-5,463,889,618
516,338,253
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.